TFCP2L1 Polyclonal antibody

TFCP2L1 Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, ELISA

Conjugate

Unconjugated

Cat no : 14248-1-AP

Synonyms

CRTR 1, CRTR1, LBP 9, LBP9, TFCP2L1, Transcription factor LBP 9



Tested Applications

Positive WB detected inhuman placenta tissue

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Published Applications

WBSee 1 publications below

Product Information

14248-1-AP targets TFCP2L1 in WB, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen TFCP2L1 fusion protein Ag5520
Full Name transcription factor CP2-like 1
Calculated Molecular Weight 55 kDa
Observed Molecular Weight 55 kDa
GenBank Accession NumberBC064698
Gene Symbol TFCP2L1
Gene ID (NCBI) 29842
RRIDAB_2878034
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Transcription factor CP2-like protein 1 (TFCP2L1) is a transcriptional regulator critical for maintaining mouse and human embryonic stem cell (ESC) pluripotency. The deletion of TFCP2L1 in mice reduced the expression of renal cell markers including ion transporters and cell identity proteins expressed in different segments of the distal nephron (PMID: 33097957).

Protocols

Product Specific Protocols
WB protocol for TFCP2L1 antibody 14248-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Int J Chron Obstruct Pulmon Dis

Analysis of Key Genes and miRNA-mRNA Networks Associated with Glucocorticoids Treatment in Chronic Obstructive Pulmonary Disease

Authors - Jian-Jun Wu